Systemic Immune-Inflammatory Index (SII) as a Biomarker for Metastatic Non-Small Cell Lung Cancer

被引：0
|
作者：
Asif, S. [1 ]
Kesireddy, M. [1 ]
Ganti, A. K. [1 ]
Marr, A. [1 ]
Buddharaju, L. N. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Hematol Oncol, Omaha, NE USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
Systemic immune-inflammatory index; NSCLC; Biomarker;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P60.08
引用
收藏
页码：S1167 / S1168
页数：2
相关论文
共 50 条
  • [31] Predictive biomarker testing rates in patients with metastatic non-small cell lung cancer in The Netherlands
    de Jager, V.
    Garcia, B. N. Cajiao
    Kuijpers, C. C.
    de Bock, G. H.
    Maas, W. J.
    Timens, W.
    van Kempen, L. C.
    van der Wekken, A. J.
    Schuuring, E.
    Willems, S. M.
    VIRCHOWS ARCHIV, 2024, 485 : S139 - S140
  • [32] Immune Signatures of Non-Small Cell Lung Cancer
    Green, Susan
    Dawe, David E.
    Banerji, Shantanu
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) : 913 - 915
  • [33] The Diagnostic Value of Systemic Immune-Inflammatory Index (SII) and Lymphocyte- Albumin-Neutrophil Ratio (LANR) in Chronic Obstructive Pulmonary Disease with Lung Cancer
    Xu, Yidan
    Zhang, Lu
    Chen, Zhiyang
    Sun, Xiaonan
    Zhao, Mengdan
    Wu, Qirui
    Hao, Jiqing
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 5555 - 5565
  • [34] Collagen XXIII: A biomarker for non-small cell lung cancer
    Spivey, Kristin A.
    Banyard, Jacqueline
    Solis, Luisa M.
    Wistuba, Ignacio I.
    Barletta, Justine A.
    Gandhi, Leena
    Feldman, Henry A.
    Rodig, Scott J.
    Chirieac, Lucian R.
    Zetter, Bruce R.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [35] BIOMARKER FOR BRAIN METASTASIS OF NON-SMALL CELL LUNG CANCER
    Yang, Seung-Ho
    Yoo, Jin Young
    Cho, Deog Gon
    Kim, Hoo Kyo
    Kim, Sung Whan
    Lee, Sang Won
    NEURO-ONCOLOGY, 2010, 12 : 64 - 64
  • [36] Osteopontin is a prognostic biomarker in non-small cell lung cancer
    Rud, Ane Kongsgaard
    Boye, Kjetil
    Oijordsbakken, Miriam
    Lund-Iversen, Marius
    Halvorsen, Ann Rita
    Solberg, Steinar K.
    Berge, Gisle
    Helland, Aslaug
    Brustugun, Odd Terje
    Maelandsmo, Gunhild M.
    BMC CANCER, 2013, 13
  • [37] Impact of lung biomarker testing on out-of-pocket costs for metastatic non-small cell lung cancer
    Gharzai, Laila A.
    Bell, Sarah
    Gupta, Divya Myadam
    Carlos, Ruth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis
    Zhou, Yuting
    Dai, Menglu
    Zhang, Zongxin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Development and validation of a computed tomography–based immune ecosystem diversity index as an imaging biomarker in non-small cell lung cancer
    Lan He
    Zhen-Hui Li
    Li-Xu Yan
    Xin Chen
    Sebastian Sanduleanu
    Wen-Zhao Zhong
    Phillippe Lambin
    Zhao-Xiang Ye
    Ying-Shi Sun
    Yu-Lin Liu
    Jin-Rong Qu
    Lin Wu
    Chang-Ling Tu
    Madeleine Scrivener
    Thierry Pieters
    Emmanuel Coche
    Qian Yang
    Mei Yang
    Chang-Hong Liang
    Yan-Qi Huang
    Zai-Yi Liu
    European Radiology, 2022, 32 : 8726 - 8736
  • [40] Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Shoji, Fumihiro
    Takeoka, Hiroaki
    Kozuma, Yuka
    Toyokawa, Gouji
    Yamazaki, Koji
    Ichiki, Masao
    Takeo, Sadanori
    LUNG CANCER, 2019, 136 : 45 - 51
12345